Declaración de accesibilidad Saltar la navegación
  • Volver a los sitios globales
  • +44 (0)20 7454 5110
  • GDPR
  • Periodistas
  • Solicitar más información
PR Newswire: news distribution, targeting and monitoring
  • Noticias
  • Productos
  • Contacto
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Solicitar más información
    • Teléfono

    • +44 (0)20 7454 5110 de 8 AM - 5 PM GMT

    • Contáctenos
    • Contáctenos

      +44 (0)20 7454 5110
      de 8 AM - 5 PM GMT

  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR

MESI, Ltd. earns the MDSAP certification
  • USA - English
  • España - español
  • France - Français
  • Deutschland - Deutsch

MESI

Noticias proporcionadas por

MESI

20 jul, 2021, 11:26 GMT

Compartir este artículo

Share toX

Compartir este artículo

Share toX

LJUBLJANA, Slovenia, July 20, 2021 /PRNewswire/ -- MESI, Ltd is pleased to announce that they have successfully added the certificate for conformance with ISO 13485:2016/MDSAP (Medical Device Single Audit Program) to their array of international certifications, including EC and FDA. Following an extensive audit by DQS GmbH, the certificate was awarded to MESI in the beginning of July 2021.

Continue Reading
MESI mTABLET MDSAP certified
MESI mTABLET MDSAP certified

Medical Device Single Audit Program (MDSAP) was established by the International Medical Device Regulators Forum (IMDRF) to allow the conduct of a single regulatory audit of a medical device manufacturer's quality management system. The aim is to satisfy the requirements of multiple regulatory jurisdictions and improve medical device safety benefitting both the industry and the end user. 

MDSAP represents the highest quality regulatory standard in the medical device manufacturing industry, and it satisfies the relevant requirements of the regulatory authorities participating in the program, including Canada, the United States, Brazil, Australia, and Japan.

"To MESI, this milestone represents the ultimate recognition by regulatory authorities of the effort to maintain the highest quality standards. The obtained certification was a result of strict review of all internal and external processes, and we are proud of the fact that we can now serve an even wider market with our top-notch diagnostic devices," says Jakob Šušterič, CEO of MESI. This brings MESI one step closer to fulfilling the company's mission: bringing timely diagnostics and, consequently, successful treatment into healthcare practices across the globe.

About the company:

MESI, Ltd. is an innovation-driven company focused on simplifying diagnostics, providing clinicians with predictive medical assessment. MESI wireless technology, such as 12-lead ECG, Spirometer, Blood Pressure, Pulse Oximeter, Ankle-Brachial and Toe-Brachial Index devices, help them discover diseases in the early stages and ensure all patients receive successful treatment. The solutions fit into all medical environments, from individual practices to hospitals and home care. With strong in-house research & development and a certified production facility, MESI is a trustworthy provider of digital and connected diagnostic devices.

Contact:         
Manca Uršič Rosas
+386 51 656 292
[email protected]


Photo- https://mma.prnewswire.com/media/1577600/MESI_mTABLET.jpg

Logo- https://mma.prnewswire.com/media/1470860/MESI_Logo.jpg

Modal title

Contacte con PR Newswire

  • +44 (0)20 7454 5110
    de 8 AM - 5 PM GMT

Sitios globales

  • APAC
  • APAC - Chino Tradicional
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania

 

  • India
  • Indonesia
  • Israel
  • Italia
  • México
  • Oriente Medio
  • Oriente Medio - Árabe
  • Países Bajos
  • Noruega
  • Polonia

 

  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contacte con PR Newswire

Sitios globales
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania
  • India
  • Israel
  • Italia
  • México
  • Medio Oriente
  • Países Bajos
  • Noruega
  • Polonia
  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos
+44 (0)20 7454 5110
de 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.